June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Cell Culture Substrates comparison on Modulating Survival and Neurite Outgrowth of Retinal Ganglion Cell
Author Affiliations & Notes
  • John Dayron Rivera
    Schepen's Eye Research Institute, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Jonathan Soucy
    Schepen's Eye Research Institute, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Volha Malechka
    Schepen's Eye Research Institute, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Emil Kriukov
    Schepen's Eye Research Institute, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Petr Y Baranov
    Schepen's Eye Research Institute, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   John Dayron Rivera None; Jonathan Soucy None; Volha Malechka None; Emil Kriukov None; Petr Baranov None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 3183. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      John Dayron Rivera, Jonathan Soucy, Volha Malechka, Emil Kriukov, Petr Y Baranov; Cell Culture Substrates comparison on Modulating Survival and Neurite Outgrowth of Retinal Ganglion Cell. Invest. Ophthalmol. Vis. Sci. 2023;64(8):3183.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Optimization of retinal ganglion cell (RGC) survival and maturation is essential to improve the efficacy of RGC replacement therapy for patients with optic neuropathies. Laminin, a protein in the CNS and retinal extracellular matrix (ECM), can bind and activate the β1 Integrin receptor on RGCs and is required to maintain RGC culture in 2D in vitro. It is necessary for cell adhesion and survival to promote the extension of neurites, synapse formation, and intercellular signaling. In this study, we explored minor laminin-derived protein (iMatrix 511) and other ECM ligands as a substrate and supplement for 2D RGC culture.

Methods : Human RGCs for the studies were differentiated and purified from brn3b-tdTomato-hESC using a 2D RGC differentiation protocol. To study RGC-substrate interaction, we seeded cells (13.9k/well) into substrate-coated wells of 96 well plates containing: iMatrix511, matrigel, laminin, poly-d-lysine (PDL)+laminin, PDL+BB(borate buffer), PDL alone, geltrex, cultrex, collagen 1, fibronectin, and synthemax. The attachment of the RGCs was measured after 30 minutes of seeding. Cell viability was assessed with Calcein blue at 1 hr post-plating and neurite outgrowth at three days. For data analysis, ANOVA was used to measure significance.

Results : There was no attachment difference between different substrates besides PDL+BB showing a 22% RGC decrease compared to the control (p = 0.008). We observe a 20% survival increase for iMatrix 511 compared to laminin at a coat concentration of 4 ug/cm2. Besides PDL and PDL+BB, all cell culture substrates had a 40% increase in RGC neurite growth compared to the negative control. Our studies show a 48% population increase of RGC with three neurite processes for the cell culture substrate, iMatrix 511, compared to laminin (p = 0.04). Finally, the only cell culture substrates resulting in four or more primary neurites were iMatrix 511, laminin, and matrigel. Nidogen, collagen, and heparan sulfate proteoglycans—all ingredients found in matrigel, geltrex, and cultrex — did not outcompete the survival and neurite outgrowth benefits of laminin.

Conclusions : We show that iMatrix 511 is sufficient and superior to laminin as an RGC substrate in its ability to support cell survival and neurite outgrowth. Adding glycoproteins (fibronectin and synthemax), collagen, and unfixed ingredients in Matrigel, geltrex, and cultrex may induce neurite outgrowth.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×